Digital, blended lifestyle intervention program for remission and improved management of type 2 diabetes - IBIDEM

Ancora Health BV0 sites410 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sponsor

Ancora Health BV

•Diabetes: Diagnosis of T2DM without end\-organ failure
•Diagnosis of T2DM
•BMI: 25\-45 kg/m²
•Age: 18 to 75 years
•Most recent HbA1c value should be greater than 6\.0% (\>43 mmol/mol) and, if less
•than 6\.5% (\<48 mmol/mol), individuals should still be receiving anti\-diabetic
•Display interest and motivation to enroll in a digital, lifestyle intervention
•for diabetes
•Tech\-savvy \- able to fully use a smartphone/ tablet and app

•\- Serious co\-morbidities, for example, a severe form of chronic obstructive
•pulmonary disease (Gold III or IV), heart failure (classes 2\-4\) kidney failure
•(eGFR / MDRD) \<45 units, or other medically determined end\-stage organ failure,
•on active donor list
•\- Myocardial infarction, stroke, angina, or coronary insufficiency within the
•previous six months
•\- Requirement of a prescribed medical diet
•\- Weight loss of more than five kg or greater than 10% within the past six
•\- Participation in diabetes therapy within the preceding three years;
•participation in concurrent weight management or interventional research